1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is a lipid of Glycerophospholipids (GP) class. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine is associated with abnormalities such as Painful Bladder Syndrome, Dehydration, Renal tubular disorder, Gigantism and Tumor-Associated Vasculature. The involved functions are known as conjugation, Ligand Binding, Process, Laser-generated electromagnetic radiation and Blood Circulation. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine often locates in Tissue membrane, Early endosome, Body tissue, Cell surface and Membrane. The associated genes with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine are R peptide, P4HTM gene, NHS gene, TSPO gene and SLC33A1 gene. The related lipids are Liposomes, 1,2-distearoylphosphatidylethanolamine, Micelles, Fatty Acids and sialogangliosides.

Cross Reference

Introduction

To understand associated biological information of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is suspected in Renal tubular disorder, Entrapment, Painful Bladder Syndrome, Dehydration, Gigantism, Tumor-Associated Vasculature and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Hepatoblastoma D018197 10 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

Download all related citations
Per page 10 20 50 100 | Total 255
Authors Title Published Journal PubMed Link
Zorzi GK et al. Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba. 2019 Colloids Surf B Biointerfaces pmid:30384269
Williams JB et al. Codelivery of Doxorubicin and Verapamil for Treating Multidrug Resistant Cancer Cells. 2018 Pharm Nanotechnol pmid:30207210
Pawar VA et al. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis. 2018 Eur J Pharm Sci pmid:30219410
Li H et al. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice. 2018 Drug Deliv pmid:29608108
Sun Y et al. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes. 2018 Int J Nanomedicine pmid:29588589
You Y et al. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled Accumulation. 2018 Theranostics pmid:29556348
Zhang T et al. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency. 2018 Drug Deliv Transl Res pmid:29536348
Yuan S et al. Highly Sensitive Ratiometric Self-Assembled Micellar Nanoprobe for Nitroxyl and Its Application In Vivo. 2018 Anal. Chem. pmid:29332385
Chen L et al. Using PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugs. 2018 Nanoscale pmid:29308812
Qiao C et al. Intracellular accumulation and immunological responses of lipid modified magnetic iron nanoparticles in mouse antigen processing cells. 2017 Biomater Sci pmid:28516182
Gupta B et al. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin. 2017 Colloids Surf B Biointerfaces pmid:28410515
Dong Z et al. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. 2017 Biomed. Pharmacother. pmid:28236703
Pradhan P et al. Targeted Magnetic Liposomes Loaded with Doxorubicin. 2017 Methods Mol. Biol. pmid:27837546
Paolino D et al. Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation. 2017 Colloids Surf B Biointerfaces pmid:28460301
Neves AR et al. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways. 2017 Bioconjug. Chem. pmid:28355061
Lu L et al. Hydrophobic-carbon-dot-based dual-emission micelle for ratiometric fluorescence biosensing and imaging of Cu in liver cells. 2017 Biosens Bioelectron pmid:28193561
Zhu M et al. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells. 2017 Nanomedicine (Lond) pmid:28093940
Malinge J et al. Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies. 2017 Mol. Pharm. pmid:28029258
Wang F et al. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. 2017 Biomed. Pharmacother. pmid:28027535
Ahlgren S et al. Targeting lipodisks enable selective delivery of anticancer peptides to tumor cells. 2017 Nanomedicine pmid:28712916
Duan S et al. Development of a novel folate-modified nanobubbles with improved targeting ability to tumor cells. 2017 Ultrason Sonochem pmid:28427629
Zhang Y et al. Sequential self-assembly of DNA functionalized droplets. 2017 Nat Commun pmid:28623249
Liu L et al. The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer. 2017 Int J Nanomedicine pmid:28615943
Wang L et al. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions. 2017 Colloids Surf B Biointerfaces pmid:28988124
Reddy TL et al. Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma. 2016 Sci Rep pmid:27786239
Zetterberg MM et al. Optimization of lipodisk properties by modification of the extent and density of the PEG corona. 2016 J Colloid Interface Sci pmid:27592189
Lechanteur A et al. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. 2016 Eur J Pharm Sci pmid:27593989
Narayan R et al. Development of risperidone liposomes for brain targeting through intranasal route. 2016 Life Sci. pmid:27593571
Shrivastava G et al. Identification of a Nucleoporin358-Specific RNA Aptamer for Use as a Nucleus-Targeting Liposomal Delivery System. 2016 Nucleic Acid Ther pmid:27548508
Yan H et al. Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS. 2016 J. Pharm. Pharmacol. pmid:27465923
Yu MZ et al. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer. 2016 Eur J Pharm Sci pmid:27355138
Patil Y et al. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. 2016 J Control Release pmid:26809007
Moosavian SA et al. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. 2016 Colloids Surf B Biointerfaces pmid:26722819
Cheng Y et al. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation. 2016 AAPS PharmSciTech pmid:26195071
Xu Y and Meng H Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution. 2016 Artif Cells Nanomed Biotechnol pmid:25162671
Bansal D et al. Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma. 2016 Drug Deliv pmid:24786484
Hu J et al. MALDI-MS Patterning of Caspase Activities and Its Application in the Assessment of Drug Resistance. 2016 Angew. Chem. Int. Ed. Engl. pmid:27101158
Ke K et al. Influence of Phosphatidylethanolamine Concentration and Composition on the Detection of Antiphosphatidylethanolamine Antibodies by ELISA. 2016 J. Clin. Lab. Anal. pmid:27061173
Miller K et al. Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers. 2016 Nanomedicine (Lond) pmid:27003178
van der Geest T et al. Comparison of three remote radiolabelling methods for long-circulating liposomes. 2015 J Control Release pmid:26514291
Shi K et al. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. 2015 J Control Release pmid:26368312
Fang CL et al. Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study. 2015 J Control Release pmid:26164036
Hadjidemetriou M et al. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. 2015 ACS Nano pmid:26135229
Saadat E et al. Hyaluronic acid based micelle for articular delivery of triamcinolone, preparation, in vitro and in vivo evaluation. 2015 Int J Pharm pmid:25956051
Askes SH et al. Imaging the lipid bilayer of giant unilamellar vesicles using red-to-blue light upconversion. 2015 Chem. Commun. (Camb.) pmid:25940614
Jiang L et al. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. 2015 Biomaterials pmid:25818419
Li Y et al. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect. 2015 Mol. Pharm. pmid:25625539
Li Y et al. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. 2015 Biomaterials pmid:25522960
Zhai J et al. Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity. 2015 Nanoscale pmid:25516406
Poitevin M et al. Use of capillary electrophoresis as a versatile tool to measure interaction constants between a KDR-binding PEGylated lipopeptide and pegylated phospholipid micelles. 2015 Electrophoresis pmid:25257539
Wang DD et al. Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells. 2015 Biomacromolecules pmid:26588028
Masuda M et al. Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity. 2015 J. Clin. Invest. pmid:26517697
Wylie BJ et al. Dynamic nuclear polarization of membrane proteins: covalently bound spin-labels at protein-protein interfaces. 2015 J. Biomol. NMR pmid:25828256
Seo JW et al. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model. 2015 Nucl. Med. Biol. pmid:25451215
Sahu PK et al. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel. 2015 Drug Dev Ind Pharm pmid:24564799
Shi G et al. Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo. 2014 Adv Healthc Mater pmid:23798381
Li Y et al. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA. 2014 J Control Release pmid:24365128
Hashimoto Y et al. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs. 2014 Toxicol. Appl. Pharmacol. pmid:24632081
Yang Y et al. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy. 2014 Biomaterials pmid:24565519
Graham SM et al. Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes. 2014 J Control Release pmid:24368302
Lopes SC et al. Ursolic acid incorporation does not prevent the formation of a non-lamellar phase in pH-sensitive and long-circulating liposomes. 2014 Langmuir pmid:25490253
Sun Q et al. Integration of nanoassembly functions for an effective delivery cascade for cancer drugs. 2014 Adv. Mater. Weinheim pmid:25328159
Li Y et al. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy. 2014 Bioconjug. Chem. pmid:25260060
Saadat E et al. Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation. 2014 Int J Pharm pmid:25148729
Rüger R et al. In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. 2014 J Control Release pmid:24810115
Zariwala MG et al. Ascorbyl palmitate/DSPE-PEG nanocarriers for oral iron delivery: preparation, characterisation and in vitro evaluation. 2014 Colloids Surf B Biointerfaces pmid:24333557
Ara MN et al. Construction of an aptamer modified liposomal system targeted to tumor endothelial cells. 2014 Biol. Pharm. Bull. pmid:25366480
Mohan P et al. On-demand droplet fusion: a strategy for stimulus-responsive biosensing in solution. 2014 Langmuir pmid:25263344
Gubernator J et al. Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of epirubicin prepared using the EDTA ion gradient method. 2014 PLoS ONE pmid:24621591
Wang Y et al. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. 2014 Mol. Pharm. pmid:24579673
Honigmann A et al. STED microscopy detects and quantifies liquid phase separation in lipid membranes using a new far-red emitting fluorescent phosphoglycerolipid analogue. 2013 Faraday Discuss. pmid:23805739
Gao JQ et al. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. 2013 Biomaterials pmid:23628475
Yuba E et al. The application of pH-sensitive polymer-lipids to antigen delivery for cancer immunotherapy. 2013 Biomaterials pmid:23639528
Xia G et al. Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome. 2013 Chem. Pharm. Bull. pmid:23385961
Wu H et al. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. 2013 Biomaterials pmid:23102622
Zhang X et al. Towards an understanding of the release behavior of temperature-sensitive liposomes: a possible explanation of the "pseudoequilibrium" release behavior at the phase transition temperature. 2013 J Liposome Res pmid:23510297
Huang YC et al. Synthesis of autophagosomal marker protein LC3-II under detergent-free conditions. 2013 Angew. Chem. Int. Ed. Engl. pmid:23554020
Catania A et al. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. 2013 Breast Cancer Res. Treat. pmid:23959397
Neves LF et al. Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. 2013 Nanotechnology pmid:23975064
Abu Lila AS et al. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. 2013 Int J Pharm pmid:23928149
Akhter A et al. A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence. 2013 Int J Pharm pmid:23933440
Chong K et al. Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria. 2013 Chem. Commun. (Camb.) pmid:24064984
Xiao Y et al. Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo. 2013 Int J Nanomedicine pmid:23976853
Jee JP et al. Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer. 2012 Pharm. Res. pmid:21739321
Wang X et al. Elucidating driving forces for liposome rupture: external perturbations and chemical affinity. 2012 Langmuir pmid:22509939
Cai L et al. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo. 2012 Int J Nanomedicine pmid:22923988
Hossen MN et al. Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. 2012 J Control Release pmid:22982237
Kim HK et al. Effective targeted gene delivery to dendritic cells via synergetic interaction of mannosylated lipid with DOPE and BCAT. 2012 Biomacromolecules pmid:22229467
Gill KK et al. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. 2012 Eur J Pharm Sci pmid:22369858
Feldborg LN et al. Quantitative evaluation of bioorthogonal chemistries for surface functionalization of nanoparticles. 2012 Bioconjug. Chem. pmid:23153257
Vanić Z et al. Fusogenic activity of PEGylated pH-sensitive liposomes. 2012 J Liposome Res pmid:22149717
Xie F et al. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting. 2012 Int J Nanomedicine pmid:22275832
Domanov YA et al. Mobility in geometrically confined membranes. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21768336
Perrier T et al. OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement. 2011 Int J Pharm pmid:21839821
Nakatsuka MA et al. DNA-coated microbubbles with biochemically tunable ultrasound contrast activity. 2011 Adv. Mater. Weinheim pmid:21956383
Thimiri Govinda Raj DB et al. A novel strategy for the comprehensive analysis of the biomolecular composition of isolated plasma membranes. 2011 Mol. Syst. Biol. pmid:22027552
Fraga M et al. Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells. 2011 Int J Nanomedicine pmid:22114484
Kibria G et al. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system. 2011 Int J Pharm pmid:21414394
Zhang T et al. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. 2011 Eur J Pharm Sci pmid:21530654
Hagtvet E et al. Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice. 2011 J Drug Target pmid:21524240